TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/25/20 08:37 | 2/24/20 | IMGN | Immunogen, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Berkenblit Anna | MA | O | SVP,Chie | S | -129 | 4.99 | 0 | -26 | -21 | 98 | D | ||||||||||||||
2/25/19 10:10 | 2/22/18 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Berkenblit Anna | MA | O | VP,Chief | S | -93 | 5.60 | 0 | -17 | -12 | 119 | D | ||||||||||||||
10/17/18 09:51 | 10/16/18 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Berkenblit Anna | MA | O | VP,Chief | S | -47 | 8.00 | 0 | -6 | -4 | 133 | D | ||||||||||||||
9/11/18 17:20 | 9/10/18 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Berkenblit Anna | MA | O | VP,Chief | S | -55 | 9.46 | 0 | -6 | -4 | 139 | D | ||||||||||||||
2/23/18 11:45 | 2/21/18 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Berkenblit Anna | MA | O | VP,Chief | S | -189 | 10.88 | 0 | -17 | -11 | 144 | D | ||||||||||||||
9/18/17 11:16 | 9/13/17 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Berkenblit Anna | MA | O | VP,Chief | S | -11 | 7.00 | 0 | -2 | -1 | 162 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |